Pharmaceutical preparation, for the treatment of obesity and type II diabetes, uses associated proteins to inhibit or encourage the deposit of lipid molecules in adipocytes

摘要

A pharmaceutical preparation, for the prevention and/or treatment of obesity, using a polypeptide with a sequence identity no. 1,3,5,7,9,11,13,15,17,19,21, or 23; or a heterotrimer of alpha and beta lymphotoxin; or a nucleic acid coded for a selected polypeptide; or one or more nucleic acids coded for a heterotrimer of alpha and beta lymphotoxin; and a functional variant of their molecules, is new. ACTIVITY : Anorectic; Antidiabetic; Immunomodulator. No biological data is given. MECHANISM OF ACTION : None given.